1.

Amelioration du controle glycemique et perte de poids sous exenatide chez des patients diabetiques de type 2: resultats d'une etude retrospective observationnelle multicentrique be...

2.

Amelioration du controle glycemique et perte de poids sous exenatide chez des patients diabetiques de type 2: resultats d'une etude retrospective observationnelle multicentrique be...

3.

Amelioration du controle glycemique et perte de poids sous exenatide chez des patients diabetiques de type 2: resultats d'une etude retrospective observationnelle multicentrique be...

4.

Amelioration du controle glycemique et perte de poids sous exenatide chez des patients diabetiques de type 2: resultats d'une etude retrospective observationnelle multicentrique be...

1.

SUGAR: resultats d'une etude observationnelle belge concernant l'utilisation de la sitagliptine chez des patients diabetiques de type 2. ; Sugar: results of a Belgian observational...

2.

SUGAR: resultats d'une etude observationnelle belge concernant l'utilisation de la sitagliptine chez des patients diabetiques de type 2. ; Sugar: results of a Belgian observational...

3.

SUGAR: resultats d'une etude observationnelle belge concernant l'utilisation de la sitagliptine chez des patients diabetiques de type 2. ; Sugar: results of a Belgian observational...

4.

SUGAR: resultats d'une etude observationnelle belge concernant l'utilisation de la sitagliptine chez des patients diabetiques de type 2. ; Sugar: results of a Belgian observational...

1.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

2.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

3.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

4.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

5.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

6.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

7.

Organization of a quality-assurance project in all Belgian multidisciplinary diabetes centres treating insulin-treated diabetes patients: 5 years' experience.

1.

Belgian consensus on metabolic problems associated with atypical antipsychotics

2.

Belgian consensus on metabolic problems associated with atypical antipsychotics

3.

Belgian consensus on metabolic problems associated with atypical antipsychotics

4.

Belgian consensus on metabolic problems associated with atypical antipsychotics

1.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

2.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

3.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

4.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

5.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

6.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

7.

Effets du glimepiride (Amarylle) chez le patient diabétique de type 2: Résultats de l'étude belge RECORD en médecine générale. ; Effects of glimepiride (Amarylle) in type 2 diabeti...

1.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

2.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

3.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

4.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

5.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

6.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

7.

Belgian expert opinion: how to reduce the residual risk in atherogenic dyslipidaemic patients: place of fibrates.

1.

Controle glycemique avant et apres sitagliptine en medecine generale: analyse des facteurs determinants dans l'etude observationnelle belge "SUGAR". ; Glycaemic control before and...

2.

Controle glycemique avant et apres sitagliptine en medecine generale: analyse des facteurs determinants dans l'etude observationnelle belge "SUGAR". ; Glycaemic control before and...

3.

Controle glycemique avant et apres sitagliptine en medecine generale: analyse des facteurs determinants dans l'etude observationnelle belge "SUGAR". ; Glycaemic control before and...

4.

Controle glycemique avant et apres sitagliptine en medecine generale: analyse des facteurs determinants dans l'etude observationnelle belge "SUGAR". ; Glycaemic control before and...

1.

The Gay Men Sex Studies: Anodyspareunia Among Belgian Gay Men

2.

The Gay Men Sex Studies: Anodyspareunia Among Belgian Gay Men

3.

The Gay Men Sex Studies: Anodyspareunia Among Belgian Gay Men

1.

Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families

2.

Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families

3.

Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families

4.

Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families

1.

Predictors for remission after transsphenoidal surgery in acromegaly: a Dutch multicenter study, revised

2.

Predictors for remission after transsphenoidal surgery in acromegaly: a Dutch multicenter study, revised